Compare INMB & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INMB | MBBC |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2M | 43.4M |
| IPO Year | 2018 | N/A |
| Metric | INMB | MBBC |
|---|---|---|
| Price | $1.21 | $14.15 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.40 | N/A |
| AVG Volume (30 Days) | ★ 471.5K | 16.3K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.85 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $50,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.11 |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $9.96 |
| 52 Week High | $11.64 | $15.75 |
| Indicator | INMB | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 54.56 |
| Support Level | $1.15 | $12.90 |
| Resistance Level | $1.52 | $15.57 |
| Average True Range (ATR) | 0.08 | 0.53 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 5.79 | 53.60 |
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.